Literature DB >> 18780952

Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.

Asghar Ramyar1, Asghar Aghamohammadi, Kasra Moazzami, Nima Rezaei, Mehdi Yeganeh, Taher Cheraghi, Nima Pouladi, Golnaz Heydari, Hassan Abolhassani, Ali Akbar Amirzargar, Nima Parvaneh, Mostafa Moin.   

Abstract

Common Variable Immunodeficiency (CVID) is a heterogeneous group of disorders characterized by hypogammaglobulinemia and an increased susceptibility to recurrent infections as well as autoimmunity and malignancies. Idiopathic Thrombocytopenic Purpura (ITP) and Autoimmune Hemolytic Anemia (AIHA) are two autoimmune disorders which may be seen in association with CVID. Among 85 CVID patients, seven cases had ITP and/or AIHA (8%). Four of these patients had one or more episodes of ITP, one patient had AIHA, and two patients had both ITP and AIHA (Evans syndrome). Almost, all patients experienced chronic and recurrent infections mostly in respiratory and gastrointestinal systems during the course of the disease. Among the seven patients, five presented their underlying disease with recurrent respiratory and/or gastrointestinal tract infections, while in two remaining patients, CVID was presented with ITP. Three patients died until now; two because of hepatic failure and one due to pulmonary hemorrhage. As CVID is prone to autoimmune disorders, it should be considered as a differential diagnosis of adult-onset ITP and possibly in children. Chronic and recurrent ITP, especially in the presence of propensity to respiratory and gastrointestinal infections mandate the evaluation for an underlying immune dysregulation such as CVID.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780952     DOI: 07.03/ijaai.169175

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  7 in total

Review 1.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

2.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

3.  Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.

Authors:  Nima Rezaei; Seyed Davar Siadat; Asghar Aghamohammadi; Mostafa Moin; Zahra Pourpak; Dariush Norouzian; Jalal Izadi Mobarakeh; Mohammad Reza Aghasadeghi; Mehdi Nejati; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

4.  History of primary immunodeficiency diseases in iran.

Authors:  Asghar Aghamohammadi; Mostafa Moin; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

5.  Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy.

Authors:  Giuseppe Spadaro; Concetta D'Orio; Arturo Genovese; Antonella Galeotafiore; Chiara D'Ambrosio; Stefano Di Giovanni; Monica Vitale; Mario Capasso; Vincenzo Lamberti; Andrea Scaloni; Gianni Marone; Nicola Zambrano
Journal:  J Biomed Biotechnol       Date:  2011-09-22

6.  A girl with autoimmune cytopenias, nonmalignant lymphadenopathy, and recurrent infections.

Authors:  Marjolein A C Mattheij; Ellen J H Schatorjé; Eugenie F A Gemen; Lisette van de Corput; Peet T G A Nooijen; Mirjam van der Burg; Esther de Vries
Journal:  Case Reports Immunol       Date:  2012-11-21

7.  Integrating Clinics, Laboratory, and Imaging for the Diagnosis of Common Variable Immunodeficiency-Related Granulomatous-Lymphocytic Interstitial Lung Disease.

Authors:  Marta Dafne Cabanero-Navalon; Victor Garcia-Bustos; Leonardo Fabio Forero-Naranjo; Eduardo José Baettig-Arriagada; María Núñez-Beltrán; Antonio José Cañada-Martínez; Maria José Forner Giner; Nelly Catalán-Cáceres; Manuela Martínez Francés; Pedro Moral Moral
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.